Table 1.
Study schedule
Baseline | Allocation | Treatment phase | ||||
---|---|---|---|---|---|---|
Week 0 | Week 2 | Week 3 | Week 4 | Week 5 | Week 6 | |
Eligibility screen | √ | |||||
Inclusion/exclusion criteria | √ | |||||
Informed consent | √ | |||||
Demographics | √ | |||||
Medical history | √ | |||||
Physical examination | √ | |||||
Randomization | √ | |||||
Interventions | ||||||
Group A (acupuncture at lung meridian) |
√ | √ | √ | √ | ||
Group B (acupuncture at heart meridian) |
√ | √ | √ | √ | ||
fMRI scan | ||||||
Group A (acupuncture at lung meridian) |
√ | √ | ||||
Group B (acupuncture at heart meridian) |
√ | √ | ||||
Assessments | ||||||
AQLQ | √ | √ | ||||
ACT | √ | √ | ||||
PEF | √ | √ | ||||
SAS | √ | √ | ||||
SDS | √ | √ | ||||
MoCA | √ | √ | ||||
Participants safety | ||||||
Laboratory test | √ | √ | ||||
Adverse events | √ | √ | √ | √ |
Abbreviations: AQLQ Asthma Quality of Life Questionnaire, ACT Asthma Control Test, FEV1 Forced expiratory volume in 1 s, MoCA Montreal Cognitive Assessment, PEF Peak expiratory flow rate, SAS Self-rating Anxiety Scale, SDS Self-rating Depression Scale